comparemela.com

Latest Breaking News On - Abcellera - Page 1 : comparemela.com

AbCellera Biologics Inc (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript

AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript February 20, 2024 AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. AbCellera Biologics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. […]

H|T: The Healthtech Times – New Spring Impact Capital fund targets early-stage healthtech startups

H|T: The Healthtech Times – AbCellera denies patent infringement, Waystar eyes $8B valuation

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.